Martins et al
The Sentosa SQ HCV Genotyping Assay (VELA Diagnostics GmbH, Hamburg, Germany) is a novel deep sequencing-based in vitro diagnostic test comprising a customized version of the epMotion 5075 robotic liquid handling system for RNA extraction and sequence library preparation (Sentosa SX101), a customized version of an Ion One Touch device for template preparation including emulsion PCR (Sentosa ST401), the Ion Torrent technology for deep sequencing (Sentosa SQ301), and software for data analysis and reporting (Sentosa Link and Sentosa Reporter, respectively)
Our transparent service means that our approach remains consistent, focusing on your well-being through comprehensive care that includes doctor consultations, medication, lab work, unlimited support, and shipping with no hidden fees
KHAVINSON PEPTIDES technology has been used since 1973 and has a lot of research published on PubMed
Roches NVIDIA AI Factory: 3,500 GPUs, Digital Twins & Omniverse for GLP-1 Manufacturing Executive Summary: Roche the global biotech and diagnostics leader has dramatically scaled its AI and computing infrastructure through a new partnership with NVIDIA
Liver Transplant